117 related articles for article (PubMed ID: 10847614)
1. Bioluminescence detection of proteolytic bond cleavage by using recombinant aequorin.
Deo SK; Lewis JC; Daunert S
Anal Biochem; 2000 May; 281(1):87-94. PubMed ID: 10847614
[TBL] [Abstract][Full Text] [Related]
2. Interaction of immobilized avidin with an aequorin-biotin conjugate: an aequorin-linked assay for biotin.
Feltus A; Ramanathan S; Daunert S
Anal Biochem; 1997 Dec; 254(1):62-8. PubMed ID: 9398347
[TBL] [Abstract][Full Text] [Related]
3. Using epitope-aequorin conjugate recognition in immunoassays for complex proteins.
Desai UA; Wininger JA; Lewis JC; Ramanathan S; Daunert S
Anal Biochem; 2001 Jul; 294(2):132-40. PubMed ID: 11444808
[TBL] [Abstract][Full Text] [Related]
4. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence immunoassay for angiotensin II using aequorin as a label.
Qu X; Deo SK; Dikici E; Ensor M; Poon M; Daunert S
Anal Biochem; 2007 Dec; 371(2):154-61. PubMed ID: 17931588
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of bioluminescence-based resonance energy transfer methods for monitoring of proteolytic cleavage.
Dacres H; Dumancic MM; Horne I; Trowell SC
Anal Biochem; 2009 Feb; 385(2):194-202. PubMed ID: 19026607
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of recombinant Drosophila Copia aspartic proteinase.
Athauda SB; Yoshioka K; Shiba T; Takahashi K
Biochem J; 2006 Nov; 399(3):535-42. PubMed ID: 16813567
[TBL] [Abstract][Full Text] [Related]
8. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
[TBL] [Abstract][Full Text] [Related]
9. Fusion of Aequorea victoria GFP and aequorin provides their Ca(2+)-induced interaction that results in red shift of GFP absorption and efficient bioluminescence energy transfer.
Gorokhovatsky AY; Marchenkov VV; Rudenko NV; Ivashina TV; Ksenzenko VN; Burkhardt N; Semisotnov GV; Vinokurov LM; Alakhov YB
Biochem Biophys Res Commun; 2004 Jul; 320(3):703-11. PubMed ID: 15240105
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
11. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
[TBL] [Abstract][Full Text] [Related]
12. Interchange of aequorin and obelin bioluminescence color is determined by substitution of one active site residue of each photoprotein.
Stepanyuk GA; Golz S; Markova SV; Frank LA; Lee J; Vysotski ES
FEBS Lett; 2005 Feb; 579(5):1008-14. PubMed ID: 15710383
[TBL] [Abstract][Full Text] [Related]
13. A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening.
Bozóki B; Gazda L; Tóth F; Miczi M; Mótyán JA; Tőzsér J
Anal Biochem; 2018 Jan; 540-541():52-63. PubMed ID: 29122614
[TBL] [Abstract][Full Text] [Related]
14. Use of aequorin for G protein-coupled receptor hit identification and compound profiling.
Brough SJ; Shah P
Methods Mol Biol; 2009; 552():181-98. PubMed ID: 19513650
[TBL] [Abstract][Full Text] [Related]
15. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.
Perryman AL; Lin JH; Andrew McCammon J
Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458
[TBL] [Abstract][Full Text] [Related]
16. Design of helical proteins for real-time endoprotease assays.
Steinrücke P; Aldinger U; Hill O; Hillisch A; Basch R; Diekmann S
Anal Biochem; 2000 Nov; 286(1):26-34. PubMed ID: 11038269
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered obelin as a bioluminescent label in an assay for a peptide.
Matveev SV; Lewis JC; Daunert S
Anal Biochem; 1999 May; 270(1):69-74. PubMed ID: 10328766
[TBL] [Abstract][Full Text] [Related]
19. Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.
Cheng YS; Lo KH; Hsu HH; Shao YM; Yang WB; Lin CH; Wong CH
J Virol Methods; 2006 Oct; 137(1):82-7. PubMed ID: 16849028
[TBL] [Abstract][Full Text] [Related]
20. Application of a liposomal bioluminescent label in the development of a flow injection immunoanalytical system.
Ho JA; Huang MR
Anal Chem; 2005 Jun; 77(11):3431-6. PubMed ID: 15924372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
